GLP-1减肥药迎史上最大降价,每月245美元,Medicare将覆盖

华尔街见闻
Nov 07

美国总统特朗普周四宣布与礼来(Eli Lilly)和诺和诺德(Novo Nordisk)达成协议,大幅削减部分减肥药(包括即将上市的口服药)的价格。 根据协议,从2026年开始,患有肥胖并伴有其他疾病(如糖尿病前期或心力衰竭)的Medicare和Medicaid患者,将能以大幅降低的价格获得礼来的Zepbound和诺和诺德的Wegovy等所谓的GLP-1药物,标价约为每月245美元,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10